Successful Phase III trials at UAB contributed to the development of a novel “corrector-potentiator” combination drug therapy for cystic fibrosis patients.
As lung diseases worsen worldwide, UAB has launched a pre-doctoral training program in pulmonary research that will focus on lung diseases such as asthma, cancer, COPD, cystic fibrosis, pneumonia, lung injury and idiopathic pulmonary fibrosis.
February 10, 2017
February 10, 2017
Three UAB investigators have received innovative research grants for lung diseases from the National Institutes of Health.
February 01, 2017
UAB’s Mark Dransfield has been elected to the American Society for Clinical Investigation, an honor society for physician-scientists who have made significant contributions to better understanding of human disease.
January 30, 2017
UAB has created the only comprehensive interventional pulmonary medicine program in Alabama to better diagnose and treat lung and chest diseases.
January 26, 2017
In another example of precision medicine, UAB researchers have used IPF patients own lung tissue to create models to determine the most effective medication for that patient.
October 26, 2016
A new national, multisite study, chaired by a UAB pulmonologist, shows that supplemental oxygen does not reduce mortality or hospitalization for COPD patients with moderately low levels of blood oxygen.
Ben Branscomb, a pioneering physician and long-time UAB faculty member, was often called the father of pulmonary medicine.
March 30, 2016
Michelle Harris came to UAB on maximal life support, unsure if she would live after a rare multisystem autoimmune disease attacked her lungs. Now, she will go home with her eyes on upcoming prom and graduation.
February 29, 2016
February 23, 2016
UAB researchers probe basic molecular mechanisms that lead to the lung scarring of pulmonary fibrosis, a lethal disorder.
UAB researchers led a team that discovered that a smoking-related condition called expiratory airway collapse — often thought inconsequential — is associated with lung disease.
Telemedicine helps UAB take pulmonary rehabilitation into the home via smartphone technology, in an effort to reduce hospital readmissions from COPD.
October 08, 2015
Macrophage cells require agility to scavenge and digest dead cells and prevent an immune response to self. In lupus, the macrophages lose that agility.
A UAB researchers suggests that autoimmune disease therapy may be an effective treatment for idiopathic pulmonary fibrosis
An experimental lung-volume-reduction procedure using one-way valves shows promise for a UAB patient.
June 01, 2015
UAB’s William Bailey honored by his alma mater with a lifetime achievement award for 50 years of exemplary service in medicine.
UAB was part of a promising international study of a combination therapy for patients with the most common cystic fibrosis mutation.